Not applicableEnded earlyNCT01447901
What this trial is testing
Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Who this might be right for
Hyperlipoproteinemia Type I
Amsterdam Molecular Therapeutics 19